February 23, 2026
1 min read

CDMO Bora locks in 5-year, $250M production agreement with GSK

With a productive working relationship between the two companies already well established, Bora Pharmaceuticals is renewing a $250 million global manufacturing agreement with British drugmaker GSK.

Leave a Reply

Your email address will not be published.

Previous Story

Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says MedNews

Next Story

IMCD to acquire Willows Ingredients to expand food & nutrition presence in UK and Ireland

Previous Story

Results Outweigh Side Effects Among Ozempic/Wegovy Users, Study Says MedNews

Next Story

IMCD to acquire Willows Ingredients to expand food & nutrition presence in UK and Ireland

Latest from Blog

Go toTop